Why the study?
Does low-dose aspirin or calcium supplementation reduce platelet angiotensin II binding in pregnant women at high risk of pregnancy-induced hypertension?
Does low-dose aspirin or calcium supplementation reduce platelet angiotensin II binding in pregnant women at high risk of pregnancy-induced hypertension?
Measurement of platelet A-II binding does not provide significant additional information regarding PIH risk beyond 2nd-trimester MAP, and is not significantly altered by low-dose aspirin or calcium.
OBJECTIVES: The aims of this prospective study were to explore the changes in platelet angiotensin II (A-II) binding in pregnancy amongst Chinese women at high risk of developing pregnancy-induced hypertension (PIH) and the effects of low-dose aspirin and calcium supplementation on A-II binding. METHODS: Platelet A-II binding was assayed in 15 non-pregnant women and in 63 pregnant women determined to be at risk of PIH on the basis of 2nd-trimester mean arterial pressure (MAP). The pregnant patients were randomized into three groups: control, low-dose aspirin, and calcium supplementation. A-II binding was assayed again during the 3rd trimester in half the women and 8 weeks after delivery. RESULTS: A-II binding was negatively correlated with MAP measured in the left lateral position (p < 0.05) but not with MAP measured in the supine position. There were no significant differences between A-II binding in non-pregnant and pregnant women. Neither low-dose aspirin nor calcium supplementation caused significant reductions in A-II binding. CONCLUSION: The measurement of platelet A-II binding is unlikely to provide significant information regarding the risk of PIH over and above that obtained from measurement of 2nd-trimester MAP.
No takes yet. Share an insight, caveat, or question.
Rogers et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: